x

Search for a clinical trial

* (*) mandatory field

42 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

GERMANY

Nordrhein-Westfalen
HERNE

UNITED KINGDOM

Merseyside
LIVERPOOL

Recruiting trial
Ongoing trial
A Phase I/II Trial of TG01 and Gemcitabine as Adjuvant Therapy for Treating Patients with Resected Adenocarcinoma of the Pancreas
Royal Liverpool University Hospital NHS - Duncan Building
Molecular and Clinical Cancer Medicine

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

FRANCE

AUVERGNE-RHONE-ALPES
ADDRESS: NOT PROVIDED - FR

GERMANY

Baden-Württemberg
ULM

GERMANY

Berlin
BERLIN

Ongoing trial
CONKO-005: A prospective, randomized phase III study of adjuvant therapy of R0-resectable Pancreatic Carcinoma with Gemcitabine plus Erlotinib versus Gemcitabine for 24 weeks
Charité - Universitätsmedizin Berlin (CVK)
Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie und Tumorimmunologie

NORWAY

Østlandet
ADDRESS: NOT PROVIDED - NO

NORWAY

Østlandet
OSLO

Recruiting trial
Ongoing trial
CP4126-201 : A phase II study of CP-4126 in patients with advanced pancreatic cancer - NO
Oslo University Hospital, Ullevaal
Oslo University Hospital, Ullevål

NORWAY

Østlandet
OSLO

Recruiting trial
Ongoing trial
CP4126-201 : A phase II study of CP-4126 in patients with advanced pancreatic cancer - NO
The Norwegian Radium Hospital
Department of Clinical Cancer Research

SPAIN

Comunidad Valenciana
ALICANTE

SPAIN

Madrid
MADRID

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer (Phase II) (completed)
HM CIOCC - Centro Integral Oncológico Clara Campal
Programa de Tumores Digestivos

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

Multinational clinical trial(s)